Axerion Therapeutics

We are developing therapeutics for the management and treatment of Alzheimer's Disease and Chronic Spinal Cord Injury with IP licensed from Yale.,

  • Stage Concept Only
  • Industry Biotechnology
  • Location New Haven, CT, USA
  • Currency USD
  • Employees 7
  • Website axeriontherapeutics.com

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free